What’s Hot in HIV Treatment

What’s Hot in HIV Treatment: Expert Discussion
Join us at AIDS 2020:Virtual for this live discussion in which the expert panel explores the latest issues relating to HIV care through cases and expert dialogue followed by dedicated time to answer your questions. Topics covered will focus on key areas of HIV management, including optimal use of newer antiretroviral agents and strategies, individualizing ART for women of childbearing potential and during pregnancy, the impact of evolving data on adverse events during ART, and the anticipated roles of emerging and investigational novel ART strategies.

Preregister here to receive email reminders and details on attending the live session, which will be available to registered delegates of AIDS 2020:Virtual, and to receive notification when the downloadable slides become available.

What’s Hot in HIV Treatment: Get The Facts
Your time is precious, so quickly get up to speed with the latest data through concise updates from the faculty, available as a 40-minute on-demand broadcast. Just search for “What’s Hot in HIV Treatment” in the “On-Demand Satellites” category in the virtual meeting to view this session, which will set the stage for the live discussion.

The live and on-demand sessions will only be available to registered participants of AIDS 2020. Register for the conference here.

Agenda

What’s Hot in HIV Treatment: Expert Discussion

Introduction (5 minutes)

Case Discussion: Navigating Current ART Options (10 minutes)

Case Discussion: Individualizing ART Based on Evolving Safety and Tolerability Data (10 minutes)

Case Discussion: Optimizing ART in Women (10 minutes) 

Expert Dialogue: Update on ART Strategies Under Investigation (10 minutes)

Question and Answer (15 minutes)

Events

Date / Time
Event Details

Faculty

Program Director
Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Faculty
Linda-Gail Bekker, FCP(SA), PhD, MBChB, DTM&H, DCH, FCP(SA), PhD

Chief Operating Officer
Desmond Tutu HIV Foundation
Deputy Director
Desmond Tutu HIV Centre
Immediate Past President
International AIDS Society
Faculty of Health Sciences
University of Cape Town,
Cape Town, South Africa

Faculty
Pedro Cahn, MD, PhD

Senior Consultant, Infectious Diseases
Hospital Juan Fernández
Director, Fundación Huesped
Professor of Infectious Diseases
Buenos Aires University Medical School
Buenos Aires, Argentina

Faculty
Laura Waters, MD

Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
CNWL NHS Trust
London, United Kingdom

Program Overview
This program is designed to improve clinician performance and patient outcomes through evidence-based expert presentations and case-based discussion on topics immediately relevant to optimal care of patients with HIV infection. This activity will feature a 40-minute pre-recorded, on-demand, didactic session followed by a 60-minute live panel discussion among expert faculty.

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in optimizing and individualizing HIV treatment for each patient, including the appropriate integration of new and emerging ART strategies.

Target Audience
The program is intended for physicians, pharmacists, and other healthcare professionals who provide care for people at risk of, or living with, HIV.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate newer ART agents into the care of people living with HIV
  • Appropriately evaluate and manage emerging adverse events associated with ART
  • Provide individualized care for key populations of patients living with HIV, such as women
  • Critically appraise the current and future role of emerging paradigms for ART

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity or enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-20-062-L02-P

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.